ALL (Acute Lymphoblastic Leukemia),Leukemia UCART19, an Allogeneic Anti-CD19 CAR-T Therapy, Shows Promise in Adults With R/R B-Cell ALL May 29, 2023
CLL (Chronic Lymphocytic Leukemia),Leukemia Phase III Trial of CPX-351 Versus 7+3 Chemo in Elderly AML Patients May 03, 2023
AML (Acute Myeloid Leukemia),Leukemia Examining the Efficacy of Gilteritinib (ASP2215) in Treating Acute Myeloid Leukemia with FLT3 Gene Mutation May 03, 2023
ALL (Acute Lymphoblastic Leukemia),Leukemia Efficacy And Safety Of Tisagenlecleucel For Treating DS-ALL In Pediatric Patients Apr 21, 2023
CLL (Chronic Lymphocytic Leukemia),Leukemia Genomic Abnormalities And Mutations Evaluated As Prognostic Factors For Therapy In Patients With CLL Apr 20, 2023
CML (Chronic Myeloid Leukemia),Leukemia Impact Of Somatic Mutations On Response To Cytoreductive Therapy In MPNs Apr 20, 2023
Leukemia Comparing CLL Therapies: Ibrutinib Monotherapy vs Venetoclax-Based Combinations in Omidubicel Phase 3 Study Apr 17, 2023
Leukemia Gilteritinib Treatment in Phase 3 ADMIRAL Trial for R/R FLT3-Mutation-Positive AML Patients Apr 17, 2023